Genomics

Dataset Information

0

Blast traumatic brain injury induced cognitive deficits are attenuated by pre- or post-injury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4 [Day 3 dataset]


ABSTRACT: Blast traumatic brain injury (B-TBI) affects military and civilian personnel. Presently there are no approved drugs for blast brain injury. Exendin-4, administered subcutaneously, was evaluated as a pre-treatment (48 hours) and post-injury treatment (2 hours) on neurodegeneration, behaviors and gene expressions in a murine open field model of blast injury. B-TBI induced neurodegeneration, changes in cognition and genes expressions linked to dementia disorders. Exendin-4, administered pre- or post-injury ameliorated B-TBI-induced neurodegeneration at 72 hours, memory deficits from days 7-14 and attenuated genes regulated by blast at day 14 post-injury. The present data suggest shared pathological processes between concussive and B-TBI, with endpoints amenable to beneficial therapeutic manipulation by exendin-4. B-TBI-induced dementia-related gene pathways and cognitive deficits in mice somewhat parallel epidemiological studies of Barnes and co-workers who identified a greater risk in US military veterans who experienced diverse TBIs, for dementia in later life.

ORGANISM(S): Mus musculus

PROVIDER: GSE71846 | GEO | 2016/08/05

SECONDARY ACCESSION(S): PRJNA292313

REPOSITORIES: GEO

Similar Datasets

2015-01-08 | E-GEOD-59646 | biostudies-arrayexpress
2013-03-18 | E-GEOD-44625 | biostudies-arrayexpress
2013-03-18 | GSE44625 | GEO
2015-01-08 | GSE59646 | GEO
2015-01-08 | E-GEOD-59645 | biostudies-arrayexpress
2016-07-01 | GSE80119 | GEO
2023-01-01 | GSE206618 | GEO
2016-05-07 | GSE80371 | GEO
2012-10-17 | GSE41345 | GEO
2024-03-04 | GSE259432 | GEO